1. A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma. (4th November 2015) Authors: Hegde, Meenakshi; Grada, Zakaria; Pignata, Antonella; Wakefield, Amanda; Fousek, Kristen; Bielamowicz, Kevin; Chow, Kevin; Brawley, Vita; Byrd, Tiara; Gottschalk, Stephen; Mukherjee, Malini; Wels, Winfried S; Baker, Matthew; Dotti, Giapietro; Orange, Jordan; Ahmed, Nabil Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A bispecific chimeric antigen receptor molecule enhances T cell activation through dual immunological synapse formation and offsets antigen escape in glioblastoma. Issue 2 (December 2015) Authors: Hegde, Meenakshi; Grada, Zakaria; Pignata, Antonella; Wakefield, Amanda; Fousek, Kristen; Bielamowicz, Kevin; Chow, Kevin; Brawley, Vita; Byrd, Tiara; Gottschalk, Stephen; Mukherjee, Malini; Wels, Winfried; Baker, Matthew; Dotti, Giapietro; Orange, Jordan; Ahmed, Nabil Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. (4th November 2015) Authors: Ahmed, Nabil; Brawley, Vita; Hegde, Meenakshi; Bielamowicz, Kevin; Wakefield, Amanda; Ghazi, Alexia; Ashoori, Aidin; Diouf, Oumar; Gerken, Claudia; Landi, Daniel; Kalra, Mamta; Yi, Zhongzhen; Rooney, Cliona; Dotti, Gianpietro; Gee, Adrian; Heslop, Helen; Gottschalk, Stephen; Powell, Suzanne; Gros... Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial. Issue 2 (December 2015) Authors: Ahmed, Nabil; Brawley, Vita; Hegde, Meenakshi; Bielamowicz, Kevin; Wakefield, Amanda; Ghazi, Alexia; Ashoori, Aidin; Diouf, Oumar; Gerken, Claudia; Landi, Daniel; Kalra, Mamta; Yi, Zhongzhen; Rooney, Cliona; Dotti, Gianpietro; Gee, Adrian; Heslop, Helen; Gottschalk, Stephen; Powell, Suzanne; Gros... Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗